CYDY is real close (3 months or so) to getting it done on their own. The window of opportunity for partnership is quickly closing, partnership will not be as beneficial after HIV BLA gets approved or Brazil trails hit pvalue even at interm status because any significant revenue will put them in control of their own destiny with all other indications such as long haulers, Nash and multiple cancers. So the way I look at it the potential partners have the best bargaining window for themselves from now until whichever 1st major catalyst is met. After that CYDY won’t need them as much and also can drive a harder bargain if they do go that route. The future looking very bright. I don’t even think anyone is selling, if shorting/MM manipulation was eliminated I think it would slowly be rising up everyday that gets closer to HIV BLA and Brazil data. Unfortunately we have to deal with it now but once there in revenue it changes everything. There will be major short covering and most won’t sell until double digits. By than large institutions will be buying up and they hold.